載入...
Drug therapy of overactive bladder - What is coming next?
After the approval and introduction of mirabegron, tadalafil, and botulinum toxin A for treatment of lower urinary tract symptoms/overactive bladder, focus of interest has been on their place in therapy versus the previous gold standard, antimuscarinics. However, since these agents also have limitat...
Na minha lista:
| 發表在: | Korean J Urol |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
The Korean Urological Association
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4610893/ https://ncbi.nlm.nih.gov/pubmed/26495067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4111/kju.2015.56.10.673 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|